Straight from Nashville, we’re just back from the annual Food and Nutrition Conference and Expo – a meeting highlighting the latest research on how foods affect our health and diseases, such as cancer risk. It’s a conference geared towards dietitians, so it’s also a place where companies showcase their health-related foods.
What were the big food trends and research takeaways related to cancer risk? Here’s a few of the conference highlights.
From the expo hall
– Beans and whole grains are big. This is a crowd that loves these foods – as do we here at AICR – but there appears to be a revival of beans and lentil products making their way into the supermarkets. There were numerous new ideas to cook with lentils, a high protein and high fiber food, including these recipes: Coconut Cream Overnight Oats and Lentils and Lentil Fudge.
For colorectal cancer, research shows that eating healthy, being active, and staying a healthy weight make a big difference in reducing the risk of developing this cancer. AICR estimates that while there are no guarantees, one of every two colorectal cancer cases can be prevented by following our recommendations.
Now a new study suggests that following AICR recommendations for prevention years before diagnosis can prolong survival for those who do develop colorectal cancer. And every recommendation followed decreased the risk of dying a little more.
How soy plays a role in breast cancer risk and recurrence is one of the most common questions we get asked. A large body of human research suggests eating tofu, soy milk and other soy foods in moderation safe. Now an animal study that may help explain what is seen in human research, shows that eating soy foods when young boosts the immune response against tumors, reducing cancer recurrence.
The study is being presented at the American Association for Cancer Research (AACR) annual meeting, and is not yet published.
Soy contains compounds called isoflavones that mimic the effect of estrogen. This raised concerns that it would stimulate breast tumors fueled by estrogen and may interfere with anti-estrogen treatment, such as tamoxifen. Early animal studies did find a link between isoflavones increasing risk of breast cancer. According to the news release, one reason may be that this early animal research used animals that do not have certain immune cells called cytotoxic T cells. These are among the cells that act against breast tumors. Read more… “Animal Study: Soy Before Puberty Reduces Breast Cancer Recurrence”
We fund cutting-edge research and give people practical tools and information to help them prevent–and survive–cancer.
American Institute for Cancer Research
P: (800) 843-8114 | Fax: (202) 328-7226